跳至主要内容
临床试验/TCTR20220926002
TCTR20220926002招募中4 期

The treatment failure and clinical efficacy comparison of budesonide metered-dose inhaler and systemic steroid in acute COPD exacerbation

Department of Emergency Medicine0 个研究点目标入组 124 人开始时间: 2022年9月26日最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
入组人数
124

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 N/A (No limit)(—)
性别
All

入选标准

  • Age at least 18 years old
  • Diagnosed with COPD by spirometry or clinical symptoms according to GOLD guideline 2022
  • Presents to emergency department with acute moderate to severe exacerbation according to GOLD guideline 2022
  • Improves after initial treatment with bronchodilator and 1 dose of intravenous dexamethasone
  • Eligible for Metered-Dose Inhaler used

排除标准

  • Acute respiratory failure
  • Hypotension despite sufficient of intravenous fluid and vasopressor
  • Pneumothorax
  • Cardiac arrest
  • Tracheostomy
  • History of systemic corticosteroid used within 1 month prior
  • Long-term oxygen therapy

研究者

相似试验

The treatment failure and clinical efficacy... | 临床试验